Paris, Octobre 2009

Poster ISPOR - Mixed treatment comparisons : an evidence-based budget impact model of Rituximab (Mabthera®) after failure of one or more TNF inhibitor therapies in the treatment of rheumatoid arthritis

Launois R, Riou-Franca L, Maunoury F